SELECTBIO Conferences Regenerative Medicine Asia 2019: Cell & Gene Therapy
Regenerative Medicine Asia 2019: Cell & Gene Therapy
Date: November 11 - 12, 2019
Venue: Kobe, Japan

Conference Chair

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Keynote Speakers

Terry Riss

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Overview

SelectBIO is pleased to welcome you to the Second Annual Regenerative Medicine Asia 2019: Cell & Gene Therapy which will be held in Kobe, Japan on November 11-12, 2019.

This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application and technologies for gene therapy.

The conference addresses the whole ecosystem of Cell & Gene Therapy and 3D-Bioprinting with a focus on 3D-Culture, Organoids, Bioprinting and Technology Platforms being developed to bring regenerative medicine to the clinic.

In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.

With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Regenerative Medicine Asia 2019: Cell & Gene Therapy.

SelectBIO is honored that Professor Norio Nakatsuji, Professor Emeritus Kyoto University will be leading the conference as Chairman and invites young scientists to submit poster abstracts to the conference and participate in the conference

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 31 October 2019

Agenda Topics

  • 3D-Bioprinting and Tissue Engineering
  • 3D-Culture and Organoids
  • Clinical Trials and Commercialization of Cell Therapies
  • Gene Therapy into the Clinic
    • Clinical Pipeline
    • Regulatory Landscape
    • Technology Platforms
  • iPSC-derived Cells for Toxicity Testing, Screening and Cellular Therapy
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
  • Stem Cells for Cellular Therapy

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Ricky Solorzano, CEO, Allevi


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks